• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Can oncology recapitulate paleontology? Lessons from species extinctions.肿瘤学能重现古生物学吗?物种灭绝带来的启示。
Nat Rev Clin Oncol. 2015 May;12(5):273-85. doi: 10.1038/nrclinonc.2015.12. Epub 2015 Feb 17.
2
Extinctions in ancient and modern seas.古代和现代海洋中的灭绝事件。
Trends Ecol Evol. 2012 Nov;27(11):608-17. doi: 10.1016/j.tree.2012.07.010. Epub 2012 Aug 10.
3
Estimates of the magnitudes of major marine mass extinctions in earth history.地球历史上主要海洋生物大灭绝规模的估计。
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6325-E6334. doi: 10.1073/pnas.1613094113. Epub 2016 Oct 3.
4
Biological extinction in earth history.地球历史上的生物灭绝。
Science. 1986 Mar 28;231:1528-33. doi: 10.1126/science.11542058.
5
The biogeographical imprint of mass extinctions.大灭绝事件的生物地理学印记。
Proc Biol Sci. 2018 May 16;285(1878). doi: 10.1098/rspb.2018.0232.
6
Comparative and population mitogenomic analyses of Madagascar's extinct, giant 'subfossil' lemurs.马达加斯加已灭绝的巨型“亚化石”狐猴的比较和群体线粒体基因组分析。
J Hum Evol. 2015 Feb;79:45-54. doi: 10.1016/j.jhevol.2014.06.016. Epub 2014 Dec 16.
7
Pleistocene extinctions: haunting the survivors.更新世大灭绝:困扰着幸存者。
Curr Biol. 2007 Aug 7;17(15):R609-11. doi: 10.1016/j.cub.2007.06.031.
8
Progress to extinction: increased specialisation causes the demise of animal clades.走向灭绝:专业化程度的提高导致动物类群的消亡。
Sci Rep. 2016 Aug 10;6:30965. doi: 10.1038/srep30965.
9
Eradicating Metastatic Cancer and the Eco-Evolutionary Dynamics of Anthropocene Extinctions.消除转移性癌症和人类世灭绝的生态进化动态。
Cancer Res. 2020 Feb 1;80(3):613-623. doi: 10.1158/0008-5472.CAN-19-1941. Epub 2019 Nov 26.
10
Human influence on distribution and extinctions of the late Pleistocene Eurasian megafauna.人类对晚更新世欧亚大陆巨型动物群分布及灭绝的影响。
J Hum Evol. 2008 Jun;54(6):769-82. doi: 10.1016/j.jhevol.2007.09.024. Epub 2008 Jan 15.

引用本文的文献

1
KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network.通过一个竞争性内源RNA(ceRNA)网络,激肽释放酶10(KLK10)/脂磷素(LIPH)/ Pard结构域蛋白6β(PARD6B)/溶质载体家族52成员3(SLC52A3)是胰腺癌预后有前景的分子生物标志物。
Heliyon. 2024 Jan 7;10(1):e24287. doi: 10.1016/j.heliyon.2024.e24287. eCollection 2024 Jan 15.
2
The future of evolutionary medicine: sparking innovation in biomedicine and public health.进化医学的未来:激发生物医学与公共卫生领域的创新。
Front Sci. 2023;1. doi: 10.3389/fsci.2023.997136. Epub 2023 Feb 28.
3
Treatment of evolving cancers will require dynamic decision support.不断演变的癌症的治疗将需要动态的决策支持。
Ann Oncol. 2023 Oct;34(10):867-884. doi: 10.1016/j.annonc.2023.08.008.
4
Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal "unity of ecology and evolution" pathological ecosystem.鼻咽癌生态学理论:癌症作为多维时空的“生态与进化统一体”病理性生态系统。
Theranostics. 2023 Mar 5;13(5):1607-1631. doi: 10.7150/thno.82690. eCollection 2023.
5
Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy.乳腺癌辅助和新辅助治疗中小群体的新型进化动力学
NPJ Breast Cancer. 2021 Mar 11;7(1):26. doi: 10.1038/s41523-021-00230-y.
6
Pancreatic cancer pathology viewed in the light of evolution.从进化角度看胰腺癌病理学。
Cancer Metastasis Rev. 2021 Sep;40(3):661-674. doi: 10.1007/s10555-020-09953-z. Epub 2021 Feb 8.
7
Phylostratic Shift of Whole-Genome Duplications in Normal Mammalian Tissues towards Unicellularity Is Driven by Developmental Bivalent Genes and Reveals a Link to Cancer.全基因组倍增在正常哺乳动物组织中的系统发生移位向单细胞性发展是由二价发育基因驱动的,并揭示了与癌症的联系。
Int J Mol Sci. 2020 Nov 19;21(22):8759. doi: 10.3390/ijms21228759.
8
Characterizing the ecological and evolutionary dynamics of cancer.描述癌症的生态和进化动态。
Nat Genet. 2020 Aug;52(8):759-767. doi: 10.1038/s41588-020-0668-4. Epub 2020 Jul 27.
9
Integrating evolutionary dynamics into cancer therapy.将进化动力学纳入癌症治疗。
Nat Rev Clin Oncol. 2020 Nov;17(11):675-686. doi: 10.1038/s41571-020-0411-1. Epub 2020 Jul 22.
10
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer.利用拮抗多效性设计化疗诱导的进化陷阱以靶向癌症耐药性
Nat Genet. 2020 Apr;52(4):408-417. doi: 10.1038/s41588-020-0590-9. Epub 2020 Mar 16.

本文引用的文献

1
Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.放射学定义的生态动力学与多形性胶质母细胞瘤的临床结局:初步结果。
Transl Oncol. 2014 Feb 1;7(1):5-13. doi: 10.1593/tlo.13730. eCollection 2014 Feb.
2
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.一种用于定量循环肿瘤DNA的超灵敏方法,具有广泛的患者覆盖范围。
Nat Med. 2014 May;20(5):548-54. doi: 10.1038/nm.3519. Epub 2014 Apr 6.
3
High-precision timeline for Earth's most severe extinction.高精度时间线:地球史上最严重的灭绝事件
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3316-21. doi: 10.1073/pnas.1317692111. Epub 2014 Feb 10.
4
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.多区域测序定义的透明细胞肾细胞癌的基因组结构和演化。
Nat Genet. 2014 Mar;46(3):225-233. doi: 10.1038/ng.2891. Epub 2014 Feb 2.
5
Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.全基因组加倍的耐受性会传播染色体不稳定性并加速癌症基因组进化。
Cancer Discov. 2014 Feb;4(2):175-185. doi: 10.1158/2159-8290.CD-13-0285. Epub 2014 Jan 19.
6
Life history trade-offs in cancer evolution.癌症进化中的生活史权衡。
Nat Rev Cancer. 2013 Dec;13(12):883-92. doi: 10.1038/nrc3606. Epub 2013 Nov 11.
7
Unraveling the therapeutic potential of the Hedgehog pathway in cancer.揭示 Hedgehog 通路在癌症治疗中的潜力。
Nat Med. 2013 Nov;19(11):1410-22. doi: 10.1038/nm.3389. Epub 2013 Nov 7.
8
The causes and consequences of genetic heterogeneity in cancer evolution.癌症进化中遗传异质性的原因和后果。
Nature. 2013 Sep 19;501(7467):338-45. doi: 10.1038/nature12625.
9
Low-dose metronomic chemotherapy: a systematic literature analysis.低剂量节拍化疗:系统文献分析。
Eur J Cancer. 2013 Nov;49(16):3387-95. doi: 10.1016/j.ejca.2013.06.038. Epub 2013 Jul 20.
10
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.APOBEC 胞嘧啶脱氨酶致突变模式广泛存在于人类癌症中。
Nat Genet. 2013 Sep;45(9):970-6. doi: 10.1038/ng.2702. Epub 2013 Jul 14.

肿瘤学能重现古生物学吗?物种灭绝带来的启示。

Can oncology recapitulate paleontology? Lessons from species extinctions.

作者信息

Walther Viola, Hiley Crispin T, Shibata Darryl, Swanton Charles, Turner Paul E, Maley Carlo C

机构信息

Evolution and Cancer Laboratory, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Translational Cancer Therapeutics Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.

出版信息

Nat Rev Clin Oncol. 2015 May;12(5):273-85. doi: 10.1038/nrclinonc.2015.12. Epub 2015 Feb 17.

DOI:10.1038/nrclinonc.2015.12
PMID:25687908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4569005/
Abstract

Although we can treat cancers with cytotoxic chemotherapies, target them with molecules that inhibit oncogenic drivers, and induce substantial cell death with radiation, local and metastatic tumours recur, resulting in extensive morbidity and mortality. Indeed, driving a tumour to extinction is difficult. Geographically dispersed species of organisms are perhaps equally resistant to extinction, but >99.9% of species that have ever existed on this planet have become extinct. By contrast, we are nowhere near that level of success in cancer therapy. The phenomena are broadly analogous--in both cases, a genetically diverse population mutates and evolves through natural selection. The goal of cancer therapy is to cause cancer cell population extinction, or at least to limit any further increase in population size, to prevent the tumour burden from overwhelming the patient. However, despite available treatments, complete responses are rare, and partial responses are limited in duration. Many patients eventually relapse with tumours that evolve from cells that survive therapy. Similarly, species are remarkably resilient to environmental change. Paleontology can show us the conditions that lead to extinction and the characteristics of species that make them resistant to extinction. These lessons could be translated to improve cancer therapy and prognosis.

摘要

尽管我们可以用细胞毒性化疗来治疗癌症,用抑制致癌驱动因子的分子来靶向癌症,并用辐射诱导大量细胞死亡,但局部和转移性肿瘤仍会复发,导致广泛的发病和死亡。事实上,将肿瘤彻底消灭是很困难的。地理上分散的生物物种可能同样难以灭绝,但在这个星球上曾经存在过的物种中,超过99.9%已经灭绝。相比之下,我们在癌症治疗方面远未达到那样的成功水平。这两种现象大致相似——在这两种情况下,一个基因多样化的群体通过自然选择发生突变和进化。癌症治疗的目标是使癌细胞群体灭绝,或者至少限制群体规模的进一步增加,以防止肿瘤负荷压垮患者。然而,尽管有可用的治疗方法,但完全缓解很少见,部分缓解的持续时间也有限。许多患者最终会因从治疗后存活下来的细胞演变而来的肿瘤而复发。同样地,物种对环境变化具有很强的适应能力。古生物学可以向我们展示导致灭绝的条件以及使物种具有抗灭绝能力的特征。这些经验教训可以转化为改善癌症治疗和预后的方法。